Cynthia Santillan

Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn’s Disease

LI-RADS: Looking Back, Looking Forward

Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn’s Disease

ACR Appropriateness Criteria® Right Lower Quadrant Pain: 2022 Update

ACR Appropriateness Criteria® Staging of Colorectal Cancer: 2021 Update

ACR Appropriateness Criteria® Hernia

ACR Appropriateness Criteria® Anorectal Disease

Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn’s Disease

An update for LI‐RADS: Version 2018. Why so soon after version 2017?

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn’s Disease by Magnetic Resonance Enterography

LI‐RADS 2017: An update

Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR)

Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study

The development of a magnetic resonance imaging index for fistulising Crohn's disease

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents

LI-RADS® ancillary features on CT and MRI

Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging

Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

Computed Tomography of Small Bowel Obstruction